Prophylactic hydration to protect renal function from intravascular iodinated contrast material

Natl Med J India. 2017 Sep-Oct;30(5):272-273. doi: 10.4103/0970-258X.234395.

Abstract

Nijssen EC, Rennenberg RJ, Nelemans PJ, Essers BA, Janssen MM, Vermeeren MA, van Ommen V, Wildberger JE. (Departments of Radiology and Nuclear Medicine, Internal Medicine, Epidemiology, Clinical Epidemiology and Medical Technology Assessment, and Cardiology, Maastricht University Medical Centre, Maastricht, The Netherlands.) Prophylactic hydration to protect renal function from intravascular iodinated contrast material in patients at high risk of contrast-induced nephropathy (AMACING): A prospective, randomised, phase 3, controlled, open-label, non-inferiority trial. Lancet 2017;389:1312-22.

Publication types

  • Clinical Trial, Phase III
  • Randomized Controlled Trial

MeSH terms

  • Contrast Media / adverse effects*
  • Fluid Therapy*
  • Humans
  • Iodine / adverse effects*
  • Kidney Diseases* / chemically induced
  • Kidney Diseases* / prevention & control
  • Kidney Diseases* / therapy
  • Practice Guidelines as Topic

Substances

  • Contrast Media
  • Iodine